AAAAAA
Results:
1-15
|
Results: 15
Authors:
de Sevaux, RGL
Gregoor, PJHS
Hene, RJ
Hoitsma, AJ
Vos, P
Weimar, W
van Gelder, T
Hilbrands, LB
Citation: Rgl. De Sevaux et al., A controlled trial comparing two doses of cyclosporine in conjunction withmycophenolate mofetil and corticosteroids, J AM S NEPH, 12(8), 2001, pp. 1750-1757
Authors:
ter Meulen, CG
Gregoor, PJHS
Weimar, W
Hilbrands, LB
Citation: Cg. Ter Meulen et al., Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone, TRANSPLAN I, 14(2), 2001, pp. 99-102
Authors:
van der Vliet, JA
Kievit, JK
Hene, RJ
Hilbrands, LB
Kootstra, G
Citation: Ja. Van Der Vliet et al., Preservation of non-heart-beating donor kidneys: A clinical prospective randomised case-control study of machine perfusion versus cold storage, TRANSPLAN P, 33(1-2), 2001, pp. 847-847
Authors:
Hordijk, W
Hoitsma, AJ
van der Vliet, JA
Hilbrands, LB
Citation: W. Hordijk et al., Results of transplantation with kidneys from non-heart-beating donors, TRANSPLAN P, 33(1-2), 2001, pp. 1127-1128
Authors:
ter Meulen, CG
Baan, CC
Hene, RJ
Hilbrands, LB
Hoitsma, AJ
Citation: Cg. Ter Meulen et al., Two doses of daclizumab are sufficient for prolonged interleukin-2R alpha chain blockade, TRANSPLANT, 72(10), 2001, pp. 1709-1710
Authors:
van Haren, FMP
Ruiter, DJ
Hilbrands, LB
Citation: Fmp. Van Haren et al., Nadroparin-induced calcinosis cutis in renal transplant recipients, NEPHRON, 87(3), 2001, pp. 279-282
Authors:
Van der Weide, MJA
Hilbrands, LB
Bemelmans, BLH
Meuleman, EJH
Frederiks, CMA
Citation: Mja. Van Der Weide et al., Lower urinary tract symptoms after renal transplantation, J UROL, 166(4), 2001, pp. 1237-1241
Authors:
Andresdottir, MB
Assmann, KJM
Hilbrands, LB
Wetzels, JFM
Citation: Mb. Andresdottir et al., Primary Epstein-Barr virus infection and recurrent type I membranoproliferative glomerulonephritis after renal transplantation, NEPH DIAL T, 15(8), 2000, pp. 1235-1237
Authors:
ter Meulen, CG
Wetzels, JFM
Hilbrands, LB
Citation: Cg. Ter Meulen et al., The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation, NEPH DIAL T, 15(5), 2000, pp. 711-714
Authors:
Andresdottir, MB
Assmann, KJM
Hilbrands, LB
Wetzels, JFM
Citation: Mb. Andresdottir et al., Type I membranoproliferative glomerulonephritis in a renal allograft: A recurrence induced by a cytomegalovirus infection?, AM J KIDNEY, 35(2), 2000, pp. E6-E12
Authors:
Koene, RAP
Hilbrands, LB
Citation: Rap. Koene et Lb. Hilbrands, Outcome of renal transplantation, LANCET, 355(9202), 2000, pp. 499-500
Authors:
Hilbrands, LB
Hordijk, W
van der Vliet, JA
Citation: Lb. Hilbrands et al., Organs for transplantation, N ENG J MED, 343(23), 2000, pp. 1731-1732
Authors:
Andresdottir, MB
Ajubi, N
Croockewit, S
Assmann, KJM
Hilbrands, LB
Wetzels, JFM
Citation: Mb. Andresdottir et al., Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange, NEPH DIAL T, 14(11), 1999, pp. 2650-2656
Authors:
van Gelder, T
Hilbrands, LB
Vanrenterghem, Y
Weimar, W
de Fijter, JW
Squifflet, JP
Hene, RJ
Verpooten, GA
Navarro, MT
Hale, MD
Nicholls, AJ
Citation: T. Van Gelder et al., A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation, TRANSPLANT, 68(2), 1999, pp. 261-266
Authors:
Gregoor, PJHS
de Sevaux, RGL
Hene, RJ
Hesse, CJ
Hilbrands, LB
Vos, P
van Gelder, T
Hoitsma, AJ
Weimar, W
Citation: Pjhs. Gregoor et al., Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients, TRANSPLANT, 68(10), 1999, pp. 1603-1606
Risultati:
1-15
|